Cargando…
Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction
BACKGROUND/AIMS: Cavernous transformation of the portal vein (CTPV) in cirrhotic patients with extrahepatic portal vein obstruction (EHPVO) was a relatively rare disease and had no consensus on the treatment. Our study aimed to explore the value of anticoagulation with warfarin treatment for CTPV ci...
Autores principales: | Zhou, Yongjie, Zhuang, Zhiquan, Yu, Tianzhu, Zhang, Wen, Ma, Jingqin, Yu, Jiaze, Yan, Zhiping, Luo, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832773/ https://www.ncbi.nlm.nih.gov/pubmed/36631860 http://dx.doi.org/10.1186/s12959-023-00449-8 |
Ejemplares similares
-
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction
por: Artru, Florent, et al.
Publicado: (2022) -
Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein
por: Li, Weixiao, et al.
Publicado: (2023) -
Extrahepatic Portal Vein Aneurysm
por: Gaba, Ron C., et al.
Publicado: (2016) -
Cavernous Transformation of Portal Vein Secondary to Portal Vein Thrombosis: A Case Report
por: Ramos, Radhames, et al.
Publicado: (2012) -
Cavernous Transformation of the Portal Vein Secondary to Cholecystolithiasis
por: Wan, Ya-Feng, et al.
Publicado: (2018)